Methylphenidate with Dicumarol Interaction Details


Brand Names Associated with Methylphenidate

  • Adhansia XR®
  • Aptensio XR®
  • Concerta®
  • Cotempla® XR-ODT
  • Jornay PM®
  • Metadate® CD
  • Metadate® ER
  • Methylin®
  • Methylin® ER
  • Methylphenidate
  • Methylphenidylacetate hydrochloride
  • Quillichew® ER
  • Quillivant® XR
  • Ritalin®
  • Ritalin® LA
  • Ritalin® SR

Medical Content Editor
Last updated Nov 09, 2023


Curious for more information about this interaction?

Ask our pharmacists directly!

Reach out to us

Interaction Effect

An increased risk of bleeding


Interaction Summary

Methylphenidate may increase the hypoprothrombinemic effect of dicumarol. Human pharmacologic studies have demonstrated that methylphenidate may inhibit the metabolism of coumarin anticoagulants, such as dicumarol. Downward dose adjustments of dicumarol may be necessary when it is used concurrently with methylphenidate. Additionally, coagulation times should be closely monitored, when initiating or discontinuing methylphenidate, and should be reassessed periodically during concurrent therapy. Dicumarol dose adjustments may be made as necessary in order to maintain the desired level of anticoagulation .


Severity

Moderate


Onset

Unspecified


Evidence

Theoretical


How To Manage Interaction

Coadministration of methylphenidate and dicumarol may increase dicumarol levels due to inhibition of dicumarol metabolism by methylphenidate. In patients receiving oral anticoagulant therapy, the prothrombin time ratio or international normalized ratio (INR) should be closely monitored with the addition and withdrawal of treatment with methylphenidate, and should be reassessed periodically during concurrent therapy. Adjustments of the dicumarol dose may be necessary in order to maintain the desired level of anticoagulation.


Mechanism Of Interaction

Inhibition of dicumarol metabolism

Methylphenidate Overview

  • Methylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Methylphenidate (Methylin) is also used to treat narcolepsy (a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep). Methylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by changing the amounts of certain natural substances in the brain.

See More information Regarding Methylphenidate

Return To Our Drug Interaction Homepage


Feedback, Question Or Comment About This Information?

Ask , our medical editor, directly! He's always more than happy to assist.


Definitions

Severity Categories

Contraindicated

These drugs, generally, should not be used together simultaneously due to the high risk of severe adverse effects. Combining these medications can lead to dangerous health outcomes and should be strictly avoided unless otherwise instructed by your provider.


Major

This interaction could result in very serious and potentially life-threatening consequences. If you are taking this drug combination, it is very important to be under close medical supervision to minimize severe side effects and ensure your safety. It may be necessary to change a medication or dosage to prevent harm.


Moderate

This interaction has the potential to worsen your medical condition or alter the effectiveness of your treatment. It's important that you are monitored closely and you potentially may need to make adjustments in your treatment plan or drug dosage to maintain optimal health.


Minor

While this interaction is unlikely to cause significant problems, it could intensify side effects or reduce the effectiveness of one or both medications. Monitoring for changes in symptoms and your condition is recommended, and adjustments may be made if needed to manage any increased or more pronounced side effects.


Onset

Rapid: Onset of drug interaction typically occurs within 24 hours of co-administration.

Delayed: Onset of drug interaction typically occurs more than 24 hours after co-administration.


Evidence

Level of documentation of the interaction.

Established: The interaction is documented and substantiated in peer-reviewed medical literature.

Theoretical: This interaction is not fully supported by current medical evidence or well-documented sources, but it is based on known drug mechanisms, drug effects, and other relevant information.


How To Manage The Interaction

Provides a detailed discussion on how patients and clinicians can approach the identified drug interaction as well as offers guidance on what to expect and strategies to potentially mitigate the effects of the interaction. This may include recommendations on adjusting medication dosages, altering the timing of drug administration, or closely monitoring for specific symptoms.

It's important to note that all medical situations are unique, and management approaches should be tailored to individual circumstances. Patients should always consult their healthcare provider for personalized advice and guidance on managing drug interactions effectively.


Mechanism Of Interaction

The theorized or clinically determined reason (i.e., mechanism) why the drug-drug interaction occurs.


Disclaimer: The information provided on this page is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional regarding your specific circumstances and medical conditions.

Where Does Our Information Come From?

Information for our drug interactions is compiled from several drug compendia, including:

The prescribing information for each drug, as published on DailyMED, is also used. 

Individual drug-drug interaction detail pages contain references specific to that interaction. You can click on the reference number within brackets '[]' to see what reference was utilized.

The information posted is fact-checked by HelloPharmacist clinicians and reviewed quarterly.